Gender blindness in agriculture and in the livestock sector in particular, continues to limit production in many rural areas, and evidence shows that the more gender inequality there is in […]

Women around the world still face many challenges and disadvantages based on their sex/gender identity, and the agriculture and livestock sectors are no exception.  Women continue to face challenges like […]

Inclusion, in its very definition, means to be open to everyone and not limited to certain people. In low-and-middle income countries, the focus for inclusion and equity has largely been […]

In a Stakeholder Seminar series led by FAO, held in January, GALVmed presented its work on small ruminant vaccines with a focus on Peste des Petits Ruminants (PPR).

Timely and effective marketing authorisation of veterinary medicines requires a combination of rigorous scientific evaluation and efficient management of procedures.  In line with GALVmed’s role in implementing the AgResults Foot […]

Small livestock are a pathway out of poverty and source of economic and gender empowerment, and yet, for millions of small-scale producers, these very important assets are threatened by diseases.

Goats, sheep, pigs, chickens. These are some of the small livestock that are giving millions of people opportunities.

Obtaining approval to sell veterinary medicines in the market requires a marketing authorisation (licence) from the National Regulatory Authority in each country where the product is to be sold.

In 2020, Oxford Policy Management (OPM) was contracted by GALVmed to implement an intervention and conduct an associated impact study on the adoption of a Newcastle Disease Vaccine (NDV) by small-scale poultry farmers in rural Tanzania in the districts of Chemba and Mbozi.

Impact is an important topic for any philanthropic organisation and GALVmed is putting this topic front and centre of our agenda for 2022.